William Wierda
MD
Section Chief, Chronic Lymphocytic Leukemia
👥Biography 个人简介
William Wierda at MD Anderson has contributed extensively to CLL clinical research across multiple generations of treatment. He was a principal investigator of the MURANO trial demonstrating venetoclax plus rituximab in relapsed/refractory CLL and has contributed to defining optimal combination regimens. His research on CAR-T therapy in CLL and novel combination approaches addresses the remaining unmet needs in this disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 William Wierda 的研究动态
Follow William Wierda's research updates
留下邮箱，当我们发布与 William Wierda（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment